PTGS2 and neoplasm: ENE and grade 2 tumours are poor prognostic indicators associated with treatment resistance and an increased likelihood of spread or recurrence, emphasising the potential for targeted treatment strategies involving PTGS2 and VEGF signalling pathway genes for optimal oncological outcomes.38